C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1997
11/06/1997	WO1997041241A1 Polycistronic expression constructs, their use and vaccines
11/06/1997	WO1997041240A1 Transgenic methods and compositions for producing parthenocarpic fruits and vegetables
11/06/1997	WO1997041239A2 Transgenic plants with enhanced sulfur amino acid content
11/06/1997	WO1997041238A1 Catalytic macro molecules having cdc25b like activity
11/06/1997	WO1997041237A1 Fungus resistant transgenic plants
11/06/1997	WO1997041236A1 Polynucleotide vaccine against canine distemper
11/06/1997	WO1997041235A2 A NEW, PIGMENT-PRODUCING, STRAIN OF $i(BACILLUS THURINGIENSIS)
11/06/1997	WO1997041234A2 PROTEINS INVOLVED IN THE SYNTHESIS AND ASSEMBLY OF O-ANTIGEN IN $i(PSEUDOMONAS AERUGINOSA)
11/06/1997	WO1997041233A1 Antiviral ricin-like proteins
11/06/1997	WO1997041232A1 Antagonists of interleukin-15
11/06/1997	WO1997041231A1 Processed polypeptides with il-16 activity, process for preparing the same and their use
11/06/1997	WO1997041230A2 Cc-type chemokines
11/06/1997	WO1997041229A1 Antibodies against interferon alpha/beta receptor
11/06/1997	WO1997041228A2 Use of the green fluorescent protein as a screenable marker for plant transformation
11/06/1997	WO1997041227A1 Plasmid-based vaccine for treating atherosclerosis
11/06/1997	WO1997041226A2 Polynucleotides encoding the transcriptional repressor gcf2 of the epidermal growth factor receptor
11/06/1997	WO1997041225A2 Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr]
11/06/1997	WO1997041224A1 Human hematopoietic stem and progenitor cell antigen and methods for its use
11/06/1997	WO1997041223A1 Molecular clone of cgrp receptor component protein and uses thereof
11/06/1997	WO1997041222A1 HUMAN P2x4 RECEPTOR SPLICE-VARIANTS
11/06/1997	WO1997041221A1 Metastasis-associated antigen and antibodies thereto
11/06/1997	WO1997041220A1 Von willebrand factor peptide derivatives and use therof as coagulant
11/06/1997	WO1997041219A1 Electrode capture of nucleic acid
11/06/1997	WO1997041218A1 Herbicide resistant rice
11/06/1997	WO1997041213A1 α-AMYLASE MUTANTS
11/06/1997	WO1997041210A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
11/06/1997	WO1997041209A1 Pluripotent rabbit embryonic stem (es) cell lines and their use in the generation of chimeric rabbits
11/06/1997	WO1997041207A2 Expression of soluble heterologous proteins in bacteria utilizing a thioredoxin/protein expression vector
11/06/1997	WO1997041156A1 Novel compounds
11/06/1997	WO1997041154A1 Eosinophil eotaxin receptor
11/06/1997	WO1997041152A1 Scarecrow gene, promoter and uses thereof
11/06/1997	WO1997041151A2 Choline binding proteins for anti-pneumococcal vaccines
11/06/1997	WO1997041147A1 Novel compounds
11/06/1997	WO1997041146A1 Novel compounds
11/06/1997	WO1997041142A1 Nanoconstructions of geometrical objects and lattices from antiparallel nucleic acid double crossover molecules
11/06/1997	WO1997041141A1 Methods and compounds for curing diseases caused by mutations
11/06/1997	WO1997041135A1 Novel compounds
11/06/1997	WO1997040857A1 Drug delivery using terminal complement components
11/06/1997	WO1997040855A1 Mammalian regulator of nonsense-mediated rna decay
11/06/1997	WO1997040852A1 Improving binding affinity of antigenic peptides for mhc molecules
11/06/1997	WO1997040851A1 Novel compounds
11/06/1997	WO1997040839A1 Dna vaccine formulations
11/06/1997	WO1997040698A1 Soybean oil having high oxidative stability
11/06/1997	WO1997040679A1 Methods for delivering compounds into a cell
11/06/1997	WO1997035969A3 Peptide ligands of the urokinase receptor
11/06/1997	WO1997035471A3 Use of aromatic aldehydes as pesticides
11/06/1997	WO1997027284A3 Human rad50 and septin-2 genes and methods of use
11/06/1997	WO1997025432A3 Improved mutants of (2,5 dkg) reductase
11/06/1997	WO1997024452A3 Toxic-protein expressing viruses and producer cell lines
11/06/1997	DE19713086A1 Detection of nucleic acids by phosphate(s) of fluorescein derivatives
11/06/1997	DE19617687A1 Verfahren zur Herstellung transgener, Inulin erzeugender Pflanzen A method for producing transgenic, inulin-producing plants
11/06/1997	DE19617203A1 Recombinant interleukin 16
11/06/1997	DE19617202A1 Recombinant interleukin 16
11/06/1997	CA2253595A1 Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins
11/06/1997	CA2253433A1 Mammalian regulator of nonsense-mediated rna decay
11/06/1997	CA2253292A1 Transgenic plants with enhanced sulfur amino acid content
11/06/1997	CA2253259A1 Processed polypeptides with il-16 activity, process for preparing the same and their use
11/06/1997	CA2253252A1 Choline binding proteins for anti-pneumococcal vaccines
11/06/1997	CA2253245A1 Fungus resistant transgenic plants
11/06/1997	CA2253233A1 Process for producing maturation bone morphogenetic protein
11/06/1997	CA2253229A1 Polynucleotide vaccine against canine distemper
11/06/1997	CA2252850A1 Eosinophil eotaxin receptor
11/06/1997	CA2252762A1 Methods and compounds for curing diseases caused by mutations
11/06/1997	CA2252705A1 Scarecrow gene, promoter and uses thereof
11/06/1997	CA2252675A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
11/06/1997	CA2252617A1 Methods for delivering compounds into a cell
11/06/1997	CA2252557A1 Antagonists of interleukin-15
11/06/1997	CA2252542A1 Dna, rna and a protein useful for detection of a mycobacterial infection
11/06/1997	CA2252524A1 Pluripotent rabbit embryonic stem (es) cell lines and their use in the generation of chimeric rabbits
11/06/1997	CA2252432A1 Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr]
11/06/1997	CA2250759A1 A cytoplasmic gene expression system which utilizes a prokaryotic rna polymerase autogene
11/06/1997	CA2250428A1 Plasmid-based vaccine for treating atherosclerosis
11/06/1997	CA2230866A1 Human p2x4 receptor splice-variants
11/05/1997	EP0805213A2 Detection of mycobacteria by multiplex nucleic acid amplification
11/05/1997	EP0805209A2 Nucleic acid construct with genes coding for transportsignals
11/05/1997	EP0805208A1 Promoter/terminator of formate dehydrogenase gene of candida boidinii
11/05/1997	EP0805207A1 Polycistronic expression plasmid for tumor rejection
11/05/1997	EP0805206A2 Human cartilage glycoprotein
11/05/1997	EP0805205A1 Nitrate reduction system of Staphylococcus carnosus
11/05/1997	EP0805203A1 The use of a substance which prevents HGS/SF from binding with Met
11/05/1997	EP0805202A1 Yeast, and food and drink containing the same
11/05/1997	EP0805190A2 Energy transfer dyes with enhanced fluorescence
11/05/1997	EP0805160A1 Nucleic acid-bound polypeptide, method of producing nucleic acid-bound polypetide, and immuoassay using the polypeptide
11/05/1997	EP0804731A1 Method and apparatus for fabricating microarrays of biological samples
11/05/1997	EP0804728A1 Assay, receptor proteins and ligands
11/05/1997	EP0804619A1 Nucleic acid probes for the detection and identification of fungi
11/05/1997	EP0804618A2 Compound microsatellite primers for the detection of genetic polymorphisms
11/05/1997	EP0804617A1 Bcl-x/bcl-2 associated cell death regulator
11/05/1997	EP0804616A2 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
11/05/1997	EP0804615A1 Apolipoprotein e polymorphism and treatment of alzheimer's disease
11/05/1997	EP0804613A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins
11/05/1997	EP0804611A1 Direct detection of expanded nucleotide repeats in the human genome
11/05/1997	EP0804605A2 Liposome-mediated transfection of central nervous system cells
11/05/1997	EP0804604A2 Method to improve screening efficiency in fused cells
11/05/1997	EP0804603A1 Use of a bacterial component to enhance targeted delivery of polynucleotides to cells
11/05/1997	EP0804602A1 Hsv viral vector
11/05/1997	EP0804601A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
11/05/1997	EP0804600A1 The cytoplasmic inhibition of gene expression
11/05/1997	EP0804599A1 Mannose or xylose based positive selection
11/05/1997	EP0804598A1 Recombinant rna viral vector and method of preparing the same

1 ... 3584 3585 3586 3587 3588 3589 3590 3591 3592 3593 3594 3595 3596 3597 3598 3599 3600 3601 3602 3603 3604 ... 4023